Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to confirm the association between hypermobile Ehlers Danlos syndrome (hEDS) and mast cell activation syndrome (MCAS) in patients with digestive disorders managed in allergology departments.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Determine the presence of mast cell activation syndrome | Other | Mast cell activation syndrome will be confirmed if the following three conditions are met (according to Valent et al, 2012) :
Mast cell activation syndrome will be possible if :
|
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of mast cell activation syndrome in patients with hypermobile Ehlers Danlos syndrome with digestive disorders | The presence of mast cell activation syndrome will be described in three modalities : confirmed, possible, and unlikely. Mast cell activation syndrome will be confirmed if the following three conditions are met :
Mast cell activation syndrome will be possible if:
| 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Frequency of the symptoms after treatment with anti-histamines | Symptoms are those established by Valent et al, 2012. For each clinical sign the patient will rate the frequency of the symptom: more than once a day, once a day, 2 to 6 times a week, once or less a week, never, over the two months prior to visit 1 (V1), and between V1 and the 2-month follow-up visit . | 2 months |
Not provided
Inclusion Criteria:
Additional criteria for minors :
- No objection to the use of health data for research purposes by parents/guardians
Exclusion Criteria:
under guardianship or curatorship
having taken a long-term high-dose antihistamine treatment (H1 or H2) during the last two months, according to the following thresholds :
Patients deprived of liberty, pregnant or nursing women
Not provided
Not provided
Not provided
Subjects with EDSh with digestive disorders
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marie DE SOLERE | Contact | +33320225269 | drci@ghicl.net | |
| William's VAN DEN BERGHE, CRA | Contact | +33320225731 | VanDenBerghe.Williams@ghicl.net |
| Name | Affiliation | Role |
|---|---|---|
| Juliette CARON, Md | Lille Catholic University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint-Vincent-de-Paul hospital | Recruiting | Lille | Nord | 59020 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D030342 | Genetic Diseases, Inborn |
| D009325 | Nausea |
| D006356 | Heartburn |
| D000090267 | Mast Cell Activation Syndrome |
| ID | Term |
|---|---|
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
basal tryptase blood test
| Medical Outcome Study Short-Form 36 (MOS SF-36 ) survey after antihistamine treatment | MOS SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability | 2 months |
| Frequency of consumption of analgesics | The frequency of consumption of different analgesics will be studied over the two months preceding V1 and between V1 and V2. | 2 months |
| Frequency of intolerance according to particular food consumption | For a given food, at V1 and V2, intolerance will be qualified by the presence of digestive disorders following the consumption of the food among : cow's milk, goat's milk, sheep's milk, fresh cheeses, cow's milk cheese or yogurt, goat's milk cheese or yogurt, sheep's milk cheese or yogurt, wheat/gluten, dry sausage, ham, turkey, chicken, pork, beef, raw egg, cooked egg, smoked fish, canned fish fresh fish, shellfish, mollusks, tomatoes, potatoes, spinach, peas, cabbage, lentils, beans, lemons, oranges, strawberries, raspberries, pineapple, mango, apple, pear, nectarine, peach, banana, kiwi, nuts, peanuts, spices, beers, wines, spirits, other. | 2 months |
| D000090362 | Mast Cell Activation Disorders |
| D007154 | Immune System Diseases |